UBS O'Connor’s ONYX PHARMACEUTICALS INC ONXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2013
Q4
Sell
-484,886
Closed -$60.5M 565
2013
Q3
$60.5M Buy
484,886
+444,886
+1,112% +$56.3M 1.26% 10
2013
Q2
$3.47M Buy
+40,000
New +$3.68M 0.07% 275

UBS O'Connor's ONXX Position: Q4 2013 in Review

UBS O'Connor sold out of ONYX PHARMACEUTICALS INC (ONXX) in Q4 2013, closing a stake of 484,886 shares — an estimated $60.5M sold.

UBS O'Connor first reported a position in ONXX in Q2 2013 and held it in 2 quarters. The position peaked at $60.5M in Q3 2013. 0 funds tracked by Wall St. Rank hold ONXX as of Q4 2013.

  • UBS O'Connor reported no remaining ONYX PHARMACEUTICALS INC position as of Q4 2013 after selling out during the quarter.
  • UBS O'Connor sold 484,886 ONYX PHARMACEUTICALS INC shares in Q4 2013, an estimated $60.5M.
  • UBS O'Connor first reported a position in ONYX PHARMACEUTICALS INC in Q2 2013 and held it in 2 quarters.
  • UBS O'Connor's ONYX PHARMACEUTICALS INC position peaked at $60.5M in Q3 2013.
  • 0 funds tracked by Wall St. Rank held ONYX PHARMACEUTICALS INC as of Q4 2013.

Based on UBS O'Connor's 13F filing for Q4 2013, filed 13 Feb 2014.